4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide

C97H106N26O11 — CID 157128247

IUPAC4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide
SMILESCC(C)(C)c1cc(CC(=O)Nc2ccc(-n3nc(-c4ccc(C(=O)NC5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1.CC(C)(C)c1cc(CC(=O)Nc2ccc(-n3nc(-c4ccc(C(=O)NN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1.CC(C)N1CCN(C(=O)c2ccc(-c3nn(-c4ccc(NC(=O)Cc5cc(C(C)(C)C)on5)cc4)c4ncnc(N)c34)cc2)CC1
InChIInChI=1S/C34H39N9O3.C32H34N8O4.C31H33N9O4/c1-21(2)41-14-16-42(17-15-41)33(45)23-8-6-22(7-9-23)30-29-31(35)36-20-37-32(29)43(39-30)26-12-10-24(11-13-26)38-28(44)19-25-18-27(46-40-25)34(3,4)5;1-32(2,3)25-16-23(39-44-25)17-26(41)36-21-8-10-24(11-9-21)40-30-27(29(33)34-18-35-30)28(38-40)19-4-6-20(7-5-19)31(42)37-22-12-14-43-15-13-22;1-31(2,3)24-16-22(38-44-24)17-25(41)35-21-8-10-23(11-9-21)40-29-26(28(32)33-18-34-29)27(36-40)19-4-6-20(7-5-19)30(42)37-39-12-14-43-15-13-39/h6-13,18,20-21H,14-17,19H2,1-5H3,(H,38,44)(H2,35,36,37);4-11,16,18,22H,12-15,17H2,1-3H3,(H,36,41)(H,37,42)(H2,33,34,35);4-11,16,18H,12-15,17H2,1-3H3,(H,35,41)(H,37,42)(H2,32,33,34)
InChIKeyAITHQHUDSJOZLA-UHFFFAOYSA-N
MW1812.09 g/mol
LogP12.65
Rot. Bonds21

About 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide

4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide (PubChem CID 157128247) has the molecular formula C97H106N26O11 and a molecular weight of 1812.09 g/mol. Its IUPAC name is 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide.

Molecular Properties

Compound Name4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide
PubChem CID157128247
Molecular FormulaC97H106N26O11
Molecular Weight1812.09 g/mol
Exact Mass1810.85
IUPAC Name4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide
SMILESCC(C)(C)c1cc(CC(=O)Nc2ccc(-n3nc(-c4ccc(C(=O)NC5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1.CC(C)(C)c1cc(CC(=O)Nc2ccc(-n3nc(-c4ccc(C(=O)NN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1.CC(C)N1CCN(C(=O)c2ccc(-c3nn(-c4ccc(NC(=O)Cc5cc(C(C)(C)C)on5)cc4)c4ncnc(N)c34)cc2)CC1
InChIInChI=1S/C34H39N9O3.C32H34N8O4.C31H33N9O4/c1-21(2)41-14-16-42(17-15-41)33(45)23-8-6-22(7-9-23)30-29-31(35)36-20-37-32(29)43(39-30)26-12-10-24(11-13-26)38-28(44)19-25-18-27(46-40-25)34(3,4)5;1-32(2,3)25-16-23(39-44-25)17-26(41)36-21-8-10-24(11-9-21)40-30-27(29(33)34-18-35-30)28(38-40)19-4-6-20(7-5-19)31(42)37-22-12-14-43-15-13-22;1-31(2,3)24-16-22(38-44-24)17-25(41)35-21-8-10-23(11-9-21)40-29-26(28(32)33-18-34-29)27(36-40)19-4-6-20(7-5-19)30(42)37-39-12-14-43-15-13-39/h6-13,18,20-21H,14-17,19H2,1-5H3,(H,38,44)(H2,35,36,37);4-11,16,18,22H,12-15,17H2,1-3H3,(H,36,41)(H,37,42)(H2,33,34,35);4-11,16,18H,12-15,17H2,1-3H3,(H,35,41)(H,37,42)(H2,32,33,34)
InChIKeyAITHQHUDSJOZLA-UHFFFAOYSA-N
XLogP12.65
TPSA477.70 Ų
H-Bond Donors8
H-Bond Acceptors31
Rotatable Bonds21
Heavy Atoms134
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001812.09
LogP ≤ 512.65
H-Bond Donors ≤ 58
H-Bond Acceptors ≤ 1031

Analyze 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide?
The IUPAC name of 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide (CID 157128247) is 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide.
What is the SMILES notation for 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide?
The canonical SMILES for 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide is CC(C)(C)c1cc(CC(=O)Nc2ccc(-n3nc(-c4ccc(C(=O)NC5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1.CC(C)(C)c1cc(CC(=O)Nc2ccc(-n3nc(-c4ccc(C(=O)NN5CCOCC5)cc4)c4c(N)ncnc43)cc2)no1.CC(C)N1CCN(C(=O)c2ccc(-c3nn(-c4ccc(NC(=O)Cc5cc(C(C)(C)C)on5)cc4)c4ncnc(N)c34)cc2)CC1.
What is the InChIKey of 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide?
The InChIKey is AITHQHUDSJOZLA-UHFFFAOYSA-N. The full InChI is InChI=1S/C34H39N9O3.C32H34N8O4.C31H33N9O4/c1-21(2)41-14-16-42(17-15-41)33(45)23-8-6-22(7-9-23)30-29-31(35)36-20-37-32(29)43(39-30)26-12-10-24(11-13-26)38-28(44)19-25-18-27(46-40-25)34(3,4)5;1-32(2,3)25-16-23(39-44-25)17-26(41)36-21-8-10-24(11-9-21)40-30-27(29(33)34-18-35-30)28(38-40)19-4-6-20(7-5-19)31(42)37-22-12-14-43-15-13-22;1-31(2,3)24-16-22(38-44-24)17-25(41)35-21-8-10-23(11-9-21)40-29-26(28(32)33-18-34-29)27(36-40)19-4-6-20(7-5-19)30(42)37-39-12-14-43-15-13-39/h6-13,18,20-21H,14-17,19H2,1-5H3,(H,38,44)(H2,35,36,37);4-11,16,18,22H,12-15,17H2,1-3H3,(H,36,41)(H,37,42)(H2,33,34,35);4-11,16,18H,12-15,17H2,1-3H3,(H,35,41)(H,37,42)(H2,32,33,34).
What are the key properties of 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide?
4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide has a molecular weight of 1812.09 g/mol, XLogP of 12.65, 21 rotatable bonds, 8 hydrogen bond donors, and 31 hydrogen bond acceptors.
Where does this data come from?
All data for 4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-morpholin-4-ylbenzamide;4-[4-amino-1-[4-[[2-(5-tert-butyl-1,2-oxazol-3-yl)acetyl]amino]phenyl]pyrazolo[3,4-d]pyrimidin-3-yl]-N-(oxan-4-yl)benzamide;N-[4-[4-amino-3-[4-(4-propan-2-ylpiperazine-1-carbonyl)phenyl]pyrazolo[3,4-d]pyrimidin-1-yl]phenyl]-2-(5-tert-butyl-1,2-oxazol-3-yl)acetamide is sourced from PubChem (CID 157128247), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).